SCHEMBL19043183

SCHEMBL19043183

Cc1ccc(CC(C)CN2CCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.53
SIGMAR1 Q99720 3/20 0.50
CHRM2 P08172 2/20 0.50
ADRA2B P18089 2/20 0.50
DRD3 P35462 2/20 0.50
ALDH1A1 P00352 2/20 0.49
LMNA P02545 2/20 0.49
HRH1 P35367 1/20 0.47
GRIN2D O15399 4/20 0.46
GRIN3B O60391 4/20 0.46
ADRA1A P35348 4/20 0.46
GRIN1 Q05586 4/20 0.46
GRIN2A Q12879 4/20 0.46
GRIN2B Q13224 4/20 0.46
GRIN2C Q14957 4/20 0.46
GRIN3A Q8TCU5 4/20 0.46
ADRA1D P25100 2/20 0.46
ADRA1B P35368 2/20 0.46
SLC6A4 P31645 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21439343 0.98 HRH3 (0.53) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL21439516 0.98 HRH3 (0.53) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL11479249 0.86 GRIN2D (0.46) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL21439166 0.84 HRH3 (0.57) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL20382733 0.84 HRH3 (0.46) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL358258 0.84 GRIN2D (0.57) SIGMAR1GRIN2DGRIN3BADRA1AGRIN1
SCHEMBL359213 0.84 GRIN2D (0.57) SIGMAR1GRIN2DGRIN3BADRA1AGRIN1
SCHEMBL11434667 0.83 KMT2A (0.51) HRH3SIGMAR1CHRM2ADRA2BDRD3
SCHEMBL11159052 0.82 GRIN2D (0.56) HRH3SIGMAR1GRIN2DGRIN3BADRA1A
SCHEMBL9370705 0.81 SIGMAR1 (0.63) HRH3SIGMAR1DRD3ALDH1A1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2320886-B1 GLUCOSYLCERAMIDE SYNTHASE INHIBITION FOR THE TREATMENT OF COLLAPSING GLOMERULOPATHY AND OTHER GLOMERULAR DISEASE GENZYME CORP (US) 2017-06-28 EP disclosed